Philip Morris International (NYSE:PM – Get Rating) was upgraded by equities researchers at The Goldman Sachs Group from a “neutral” rating to a “buy” rating in a research report issued to clients and investors on Wednesday, The Fly reports.
Other equities research analysts have also issued research reports about the stock. Argus raised shares of Philip Morris International from a “hold” rating to a “buy” rating and set a $110.00 target price for the company in a report on Tuesday, November 15th. Stifel Nicolaus dropped their target price on shares of Philip Morris International from $115.00 to $105.00 and set a “buy” rating for the company in a report on Friday, October 14th. Jefferies Financial Group raised shares of Philip Morris International from a “hold” rating to a “buy” rating and upped their price objective for the company from $86.00 to $118.00 in a report on Thursday, January 19th. Credit Suisse Group dropped their price objective on shares of Philip Morris International to $95.00 in a report on Thursday, October 27th. Finally, Citigroup reissued a “neutral” rating and issued a $109.00 price objective on shares of Philip Morris International in a report on Tuesday, December 13th. Five analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $109.36.
Philip Morris International Stock Performance
Shares of NYSE PM opened at $101.30 on Wednesday. The firm has a market cap of $157.04 billion, a PE ratio of 18.06, a PEG ratio of 3.44 and a beta of 0.68. The firm has a fifty day moving average of $100.69 and a 200 day moving average of $95.68. Philip Morris International has a one year low of $82.85 and a one year high of $112.48.
Institutional Inflows and Outflows
Philip Morris International Company Profile
Philip Morris International, Inc is a holding company engaged in the manufacturing and sale of cigarettes, tobacco, and nicotine-containing products. Its products include cigarettes and reduced-risk products, including heat-not-burn, vapor, and oral nicotine products, which are sold in markets outside the U.S.
Read More
- Get a free copy of the StockNews.com research report on Philip Morris International (PM)
- Pliant Therapeutics Gaps 34% Higher: More Upside To Come?
- How Will Early 2023 Layoffs Affect These 5 Biotech Stocks?
- Is the Pain Over for Baudax Bio Investors after a 70% Spike?
- Will Rocket Lab’s First U.S. Launch Send Stock Into Stratosphere?
- 3 Retail Stocks Ringing the Register in 2023
Receive News & Ratings for Philip Morris International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Philip Morris International and related companies with MarketBeat.com's FREE daily email newsletter.